MedPath

Viela Bio, Inc.

Viela Bio, Inc. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
2017-01-01
Employees
170
Market Cap
-
Website
http://www.vielabio.com

Clinical Trials

15

Active:13
Completed:2

Trial Phases

2 Phases

Phase 1:10
Phase 2:4

Drug Approvals

1

FDA:1

Drug Approvals

UPLIZNA

Approval Date
Dec 23, 2020
FDA

Clinical Trials

Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials

Phase 1
10 (71.4%)
Phase 2
4 (28.6%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.